Frestedt
Frestedt Incorporated, USA
Posters-Accepted Abstracts: Pharmaceut Reg Affairs
FDA issued draft guidance about âÂ?Â?low riskâÂ? âÂ?Â?general wellnessâÂ? products in January 2015 and stated the CDRH âÂ?Â?does not intend to examine low risk general wellness products to determine whether they are devices...âÂ? This talk will review these types of products and explain the process to determine if the product is low risk and about general wellness to fit into this category.
Email: jf@frestedt.com
Pharmaceutical Regulatory Affairs: Open Access received 533 citations as per Google Scholar report